News | September 12, 2023
Indian pharma industry to witness 8-10% revenue growth in fiscal 2024: CRISIL
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The company will develop and produce premixes for human nutrition applications
The company has entered into a three-year Deferred Prosecution Agreement
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
Cipla has a robust governance model focused on sustainability
Subscribe To Our Newsletter & Stay Updated
